- Home
- WTTR vs NVAX Comparison
WTTR vs NVAX Comparison
Compare WTTR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- NVAX
- Stock Information
- Founded
- WTTR 2016
- NVAX 1987
- Country
- WTTR United States
- NVAX United States
- Employees
- WTTR N/A
- NVAX N/A
- Industry
- WTTR Oilfield Services/Equipment
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WTTR Energy
- NVAX Health Care
- Exchange
- WTTR Nasdaq
- NVAX Nasdaq
- Market Cap
- WTTR 1.3B
- NVAX 1.3B
- IPO Year
- WTTR 2017
- NVAX 1995
- Fundamental
- Price
- WTTR $12.35
- NVAX $7.99
- Analyst Decision
- WTTR Strong Buy
- NVAX Buy
- Analyst Count
- WTTR 2
- NVAX 6
- Target Price
- WTTR $16.25
- NVAX $17.83
- AVG Volume (30 Days)
- WTTR 1.0M
- NVAX 3.7M
- Earning Date
- WTTR 02-18-2025
- NVAX 02-27-2025
- Dividend Yield
- WTTR 2.27%
- NVAX N/A
- EPS Growth
- WTTR N/A
- NVAX N/A
- EPS
- WTTR 0.30
- NVAX N/A
- Revenue
- WTTR $1,452,075,000.00
- NVAX $885,193,000.00
- Revenue This Year
- WTTR $6.26
- NVAX N/A
- Revenue Next Year
- WTTR $6.87
- NVAX N/A
- P/E Ratio
- WTTR $41.04
- NVAX N/A
- Revenue Growth
- WTTR N/A
- NVAX N/A
- 52 Week Low
- WTTR $8.12
- NVAX $3.81
- 52 Week High
- WTTR $15.14
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- WTTR 40.99
- NVAX 42.04
- Support Level
- WTTR $12.24
- NVAX $7.70
- Resistance Level
- WTTR $13.50
- NVAX $8.54
- Average True Range (ATR)
- WTTR 0.54
- NVAX 0.39
- MACD
- WTTR -0.04
- NVAX -0.04
- Stochastic Oscillator
- WTTR 13.49
- NVAX 23.58
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates the majority of its revenue from Water Services.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.